TRANSPLANT GENOMICS
Transplant Genomics is a biotech company that focuses on improving organ transplant outcomes with noninvasive serial monitoring guided by genomics. Its extensive development pipeline includes diagnostic and predictive tests for kidney and liver graft dysfunction, the use of multiple sample types and technology platforms, companion diagnostics for immune suppressants and immune status tests.
TRANSPLANT GENOMICS
Industry:
Biotechnology Genetics Health Diagnostics Medical
Founded:
2013-01-01
Address:
Woodland Hills, California, United States
Country:
United States
Website Url:
http://www.trugraf.com
Total Employee:
1+
Status:
Active
Contact:
617-733-0757
Email Addresses:
[email protected]
Total Funding:
6.21 M USD
Technology used in webpage:
IPv6 Cloudflare COVID-19 Cloudflare Network Error Logging HubSpot CMS Hub Hubspot Fastly Hosted Cloudflare SSL Fastly Load Balancer Hubspot Forms
Similar Organizations
AMI
AMI is an innovative biotech company with world patented solutions.
Appiture Biotechnologies
Appiture Biotechnologies is a biotechnology research firm that focuses on the detection of autism spectrum disorder.
Applied StemCell
Applied StemCell is a biotechnology company providing animal and cell line models as tools for drug discovery and diagnostics.
Boston Genetics
Boston Genetics is a contract genomics organization.
Pathway Genomics
Pathway Genomics is a CAP accredited global clinical lab offering genetic tests for cancer risk, drug responses, and other conditions.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Tome Biosciences
Tome Biosciences is a biotechnology company that develops programmable gene insertion technology.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.trugraf.com
- Host name: 151.101.2.159
- IP address: 151.101.2.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Transplant Genomics"
Detecting Subclinical Acute Cellular Rejection | TruGraf …
TruGraf’s high negative predictive value (NPV) provides an invaluable tool for monitoring patients’ noninvasively: Data gathered from 7 transplant centers across the country showed that TruGraf concordance between product result …See details»
Our Renal Transplant Test | Transplant Genomics
TruGraf Kidney is the first and only non-invasive biomarker test approved for coverage and validated for surveillance of stable kidney transplant recipients. With TruGraf Kidney, clinicians …See details»
Post-Transplant Rejection Test | Transplant Genomics Tests
TruGraf Kidney is the first and only non-invasive biomarker test approved for coverage and validated for surveillance of stable kidney transplant recipients. With TruGraf Kidney, clinicians …See details»
Transplant Genomics - Crunchbase Company Profile
TruGraf Liver: A non-invasive blood test for liver transplant recipients to guide immunosuppression by confirming immune quiescence. Labs@HOME: A mobile phlebotomy service that allows blood draws at home for transplant patients, …See details»
TruGraf® Long-term Clinical Outcomes Study - Mayo Clinic
Selected by provider to undergo TruGraf® and TRACâ„¢ testing as part of post-transplant care. Has Medicare Part B coverage or private insurance; Exclusion Criteria: ... Mayo Clinic is a …See details»
The Only Non-Invasive Test to Rule out Silent Kidney Rejection
14. Marsh C, Kurian SM, Rice J, et al. Application of TruGraf® v1: A Novel Molecular Biomarker for Managing Kidney Transplant Recipients with Stable Renal Function. Transplantation …See details»
Transplant Genomics, Inc. Confirms TruGraf Will Receive Medicare ...
Nov 25, 2019 TruGraf is the first blood test that allows physicians to reassure patients with stable renal function following kidney transplants that their graft is not harboring silent rejection …See details»
Biomarkers of Rejection in Kidney Transplantation
Oct 15, 2024 TruGraf (Eurofins-Transplant Genomics) was the first CMS-approved GEP assay. This 57-gene microarray-based GEP was validated in the CTOT-08 Study, 46 which paired TruGraf measurements with surveillance …See details»
Application of TruGraf v1: A Novel Molecular Biomarker for …
TruGraf v1 is intended for use in subjects with stable renal function to measure the immune status as an alternative to invasive, expensive, and risky surveillance biopsies. Materials and …See details»
How to Interpret Transplant Genomics Tests
TruGraf® Kidney. The first gene expression profile test developed specifically for renal transplant recipients with focus on surveillance for patients with healthy, stable graft function. TruGraf® …See details»
Inside look: Are noninvasive biomarkers up to standard?
Oct 16, 2023 For instance, TruGraf (Transplant Genomics Inc) is a commercially available test that has been developed based on the Clinical Trials in Organ Transplantation-8 (CTOT-8) …See details»
Updates in Kidney Transplantation From the 2022 Banff-Canadian …
Nov 13, 2023 As TruGraf appears to outperform dd-cfDNA in the diagnosis of subclinical cellular rejection, and dd-cfDNA appears to outperform TruGraf in the diagnosis of subclinical AMR, …See details»
Multi-Center Validation of TruGraf V2 - A Peripheral Blood …
Importantly, TruGraf v2 called 41 phenotypes correctly that were miscalled by TruGraf v1, whereas TruGraf v1 called only 25 phenotypes correctly that were miscalled by TruGraf v2. A …See details»
CASE STUDY Long-Term Monitoring of Graft Health - Mayo
TruGraf and an at risk for rejection score from Viracor TRAC indicates this patient has a high likelihood of subclinical rejection TruGraf Result: Not-TX At risk for rejection Viracor TRAC: …See details»
Validation of Trugraf Gene Expression Profile in a Multicenter …
Prospective use of TruGraf could have eliminated 66% of surveillance biopsies accurately, while it would have been inaccurate in 29% of biopsies. *Conclusions: The high NPV of TruGraf …See details»
Improving Transplant Recipient Outcomes | Transplant Genomics
Liver. For liver transplantation, doctors study a patient’s liver disease severity, overall health, and potential for complications.They conduct blood tests, imaging scans, and assessments of liver …See details»
Investigator Assessment of the Utility of the TruGraf Molecular ...
Background: TruGraf v1 is a well-validated DNA microarray-based test that analyzes blood gene expression profiles as an indicator of immune status in kidney transplant recipients with stable …See details»
Association of Trugraf GEP with Clinical and Histological …
*Purpose: The purpose of this study was to validate the association of TruGraf GEP with clinical endpoints in a real-world cohort. *Methods: This was a multicenter observational cohort …See details»
The Real-life Experience of Developing and Commercializing …
Journal of Biochemistry and Analytical Studies, May 2020, http://dx.doi.org/10.16966/2576-5833.123 M Roy First, Steven B Kleiboeker , Stanley Rose ,See details»
Combining Blood Gene Expression and Cellfree DNA to Diagnose …
The gene expression profiles were analyzed with the TruGraf algorithm—a DNA microarray–based gene expression algorithm analyzing differential expression of 120 genes …See details»